Szu-Tah Chen
Overview
Explore the profile of Szu-Tah Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
478
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen I, Lin C, Lin C, Chen S
Front Endocrinol (Lausanne)
. 2025 Feb;
16:1511730.
PMID: 39991732
Background: To investigate the value of serum adropin in predicting chronic kidney disease (CKD) progression in subjects with type 2 diabetes (T2D). Materials And Methods: Serum adropin levels were measured...
2.
Lin Y, Lin C, Huang Y, Chen H, Tai A, Fu S, et al.
Eur J Med Res
. 2024 Nov;
29(1):565.
PMID: 39609905
No abstract available.
3.
Lin Y, Lin C, Huang Y, Tai A, Fu S, Chen S, et al.
Diabetes Res Clin Pract
. 2024 Nov;
218:111925.
PMID: 39581834
No abstract available.
4.
Huang W, Liu F, Cheng H, Tsai Y, Huang Y, Lai T, et al.
J Formos Med Assoc
. 2023 Aug;
123 Suppl 2:S82-S90.
PMID: 37633770
The prevalence of patients with primary aldosteronism (PA) is about 5%-15% in hypertensive patients, and it is common cause of secondary hypertension in clinical practice. Two major causes of PA...
5.
Lu J, Chang Y, Lee T, Wu M, Chen Z, Huang Y, et al.
J Formos Med Assoc
. 2023 Jun;
123 Suppl 2:S91-S97.
PMID: 37291044
Anti-hypertensive medications may affect plasma renin activity and/or plasma aldosterone concentration, misleading the interpretation of the aldosterone-to-renin ratio when screening for primary aldosteronism. The Task Force of Taiwan PA recommends...
6.
Lin W, Chen W, Wang P, Chan Y, Chang Y, Chen H, et al.
Ultrasonography
. 2023 Apr;
42(3):357-375.
PMID: 37072152
Radiofrequency ablation (RFA) is a minimally invasive management strategy that has been widely applied for benign and recurrent malignant thyroid lesions as an alternative to surgery in Taiwan. Members of...
7.
Lin Y, Lin C, Huang Y, Chen H, Tai A, Fu S, et al.
Eur J Med Res
. 2022 Dec;
27(1):273.
PMID: 36463197
Background: Increasing evidence suggests that glucagon-like peptide 1 (GLP-1) receptor agonists (RA) can stabilize glycemic variability (GV) and interfere with eating behavior. This study compared the impact of insulin, GLP-1...
8.
Huang Y, Wu Y, Tang H, Chen S, Wang C, Ho W, et al.
Pharmaceutics
. 2022 Sep;
14(9).
PMID: 36145605
Our previous clinical trial showed that a novel concentrated herbal extract formula, YH1 ( and Shen-Ling-Bai-Zhu-San), improved blood glucose and lipid control. This pilot observational study investigated whether YH1 affects...
9.
Li Y, Chou W, Chan W, Cheng K, Sun J, Liu F, et al.
Front Endocrinol (Lausanne)
. 2022 Apr;
13:809835.
PMID: 35432189
Background: Radiofrequency ablation (RFA) for benign thyroid nodules is one kind of scarless treatment for symptomatic or cosmetic benign thyroid nodules. However, how to train RFA-naive physicians to become qualified...
10.
Lin Y, Lin C, Huang Y, Tai A, Fu S, Chen S, et al.
Diabetes Res Clin Pract
. 2022 Mar;
186:109816.
PMID: 35247527
Aims: This retrospective study investigated the risk factors of sodium-glucose cotransporter 2 inhibitors (SGLT2i) -related genitourinary tract infection (GUTI). Methods: We used longitudinal claims data from May 2016 to December...